Teladoc Health, Inc.

TDOC Healthcare Health Information Services

Teladoc Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, down 1.54% from fiscal 2024. In the quarter to June 2026, revenue fell 3.95%, EPS fell 10.5%, free cash flow fell 27.1% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

5.67 0.30 −5.03%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
−7.7×
Dividend yield
—
F-score
5/9
Altman Z
−6.66
Beneish M
−3.26
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.54 0.49 0.39 0.62
P/FCF ratio
12.63 8.98 7.71 17.33
P/Operating CF
13.78 14.06 102.59 23.74
P/B ratio
0.98 0.89 0.73 1.17
EV/Sales
0.86 0.79 0.70 1.11
EV/EBITDA
13.21 10.79 9.38 13.51
EV/FCF
20.18 14.55 13.99 31.09
Current Ratio
2.70 2.77 2.80 0.83
Net Debt/EBITDA
5.07 3.38 7.56 4.02
Debt/Equity
0.71 0.72 0.75 0.76
Earnings Yield
(16.56%) (16.29%) (17.80%) (11.67%)
Free Cash Flow Yield
7.92% 11.13% 12.98% 5.77%
Free Cash Flow per Share
0.38 0.30 (0.15) 0.13
Book value per Share
7.87 7.86 7.46 7.24
Free Cash Flow
67.95 53.42 (26.31) 23.07
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates